Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(25%)
Results Posted
20%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph early_phase_1
1
8%
Ph not_applicable
6
50%
Ph phase_1
4
33%
Ph phase_3
1
8%

Phase Distribution

5

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
4(33.3%)
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
6(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(5)
Terminated(2)
Other(1)

Detailed Status

Completed5
Recruiting3
Terminated1
Not yet recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (8.3%)
Phase 14 (33.3%)
Phase 31 (8.3%)
N/A6 (50.0%)

Trials by Status

terminated18%
not_yet_recruiting18%
recruiting325%
withdrawn18%
completed542%
unknown18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12